Dai Huaping

Research areas: interstitial lung disease, complex respiratory diseases, diffuse parenchymal lung disease, and lung transplantation-related medical conditions.

Cutting-edge technology: Serves as the head of the Interstitial Lung Disease Group of the Chinese Medical Association's Respiratory Diseases Branch, and leads the Third Department of Respiratory and Critical Care Medicine, primarily treating patients with interstitial lung disease, diffuse parenchymal lung disease, rare respiratory diseases, or complex and difficult-to-treat conditions. Established a specialized ward and outpatient clinic for interstitial lung disease, a bronchoalveolar lavage laboratory, and a pulmonary fibrosis and lung repair laboratory, and established a multidisciplinary ward round consultation system. Promoted the construction of an integrated and standardized diagnosis and treatment system for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), encompassing screening, diagnosis, treatment, rehabilitation, and support.

Areas of expertise: Interstitial lung diseases (idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disease-associated interstitial lung disease), rare and complex respiratory diseases, and internal medicine management of lung transplantation.

Academic Highlights and Core Values: Chief Physician, Professor, Doctoral Supervisor, Director of the Third Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital. Member and Secretary of the Chinese Medical Association's Respiratory Diseases Branch, Head of the Interstitial Lung Disease Group, and a leading figure in respiratory medicine among high-level technical personnel in the Beijing Municipal Health System. He holds a nationally leading position in the field of interstitial lung disease and complex respiratory diseases, and is a core academic leader in the hospital's complex respiratory disease diagnosis and treatment system.